Kohno et al. confirmed the involvement of PPAR with fibrotic pathways because they found correlations between PPARγ ligand expression, the reduction of dermal sclerosis, and the decreased expression levels of CTGF and TGFβ in experimentally induced systemic sclerosis [144]. Here, TGFB1 is linked to systemic sclerosis.